Lindsey Silva

Lindsey Silva, Ph.D. is the Director, Microbiology in Analytical Sciences, Pharma Quality and Compliance at Genentech, a Member of the Roche Group. She and her team are responsible for driving analytical innovation and QC microbiology solutions, including end-to-end microbial oversight of a growing small molecule parenteral portfolio. Lindsey is a highly skilled analytical scientist with over 10 years of industry experience with a track record of developing and implementing technology to build agility for biologic products. Lindsey joined Genentech in 2015 as a technical development scientist responsible for virus clearance studies and development of virus testing technologies. She loves using her virology and microbiology expertise to ensure that life saving medicines are safe for patients. Lindsey is passionate about diversity and inclusion to drive innovation. Lindsey is a champion for diversifying the STEM talent pipeline as a member of Genentech Women in Science and Engineering (gWISE), an advisor for the SACNAS professional chapter at Genentech, and a board member of the non-profit ADDSTEAM. Lindsey is a recipient of the 2023 Genentech Women Professionals Emerging Leader award. Lindsey received her Bachelor of Science in Biology from UC Irvine, her Ph.D. in Microbiology and Molecular Genetics from Harvard Medical School, and post-doctoral training from USC Keck School of Medicine.

Appearances